ArticleFrontiers in public health2026
Sleepless hours: the lived experience of chronic insomnia and anxiety across the US care spectrum.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic insomnia is a prevalent condition associated with significant psychosocial and economic burden. When comorbid with Generalized Anxiety Disorder (GAD), symptom severity is intensified resulting in treatment pathways becoming more complex. Despite the impact, insomnia is often normalized, under recognized as a medical condition, and managed through fragmented care systems. Methods: A mixed-methods study was conducted in the United States to explore the patient journey of chronic insomnia with and without comorbid GAD. Qualitative insights were generated through 29 semi-structured online interviews with patients ( Results: Findings revealed substantial delays in help seeking and diagnosis, often spanning years or decades, driven by symptom normalization, stigma, and reliance on self-management remedies. Diagnosis was experienced as a moment of relief and validation, though expectations were frequently unmet due to brief consultations, limited information, and reliance on over-the-counter (OTC) options. Treatment was characterized by trial-and-error approaches, with healthcare professionals (HCP) acknowledging an overreliance on pharmacological interventions and systemic barriers to the implementation of cognitive behavioral therapy for insomnia (CBT-I). Ongoing management highlighted adaptation to insomnia as a chronic condition, emotional strain on families, and fragmented care across mental health and sleep services. Across all groups, the comorbidity of insomnia and GAD was recognized as exacerbating symptom severity and complicating management. Conclusion: This study uniquely captures the lived experience of chronic insomnia and comorbid GAD from the perspectives of patients, family members, and healthcare professionals across the US care spectrum. The findings underscore unmet psychological needs, systemic barriers to nonpharmacological interventions, and the absence of integrated, patient centered care models. Addressing these gaps requires improved recognition of insomnia as a medical condition, expansion of access to CBTI, and inclusion of family perspectives in long term management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.